撤回：重组人尿激酶原与阿替普酶治疗ST段抬高型心肌梗死的疗效及安全性比较与疗效影响因素分析
Retracted: Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Dec 13;2023:9842016. doi: 10.1155/2023/9842016. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2021/6702965.].
摘要
[本文撤回文章DOI: 10.1155/2021/6702965。]
相似文献
1
Retracted: Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy.
Evid Based Complement Alternat Med. 2023 Dec 13;2023:9842016. doi: 10.1155/2023/9842016. eCollection 2023.
2
Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.
BMC Cardiovasc Disord. 2020 Jun 26;20(1):308. doi: 10.1186/s12872-020-01584-0.
3
Efficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset: A Phase 3 Randomized Clinical Trial.
JAMA Netw Open. 2023 Jul 3;6(7):e2325415. doi: 10.1001/jamanetworkopen.2023.25415.
4
Safety and efficacy of intracoronary recombinant human prourokinase administration in patients with acute myocardial infarction and ST‑segment elevation: A meta‑analysis of randomized controlled trials.
Exp Ther Med. 2022 Nov 30;25(1):40. doi: 10.3892/etm.2022.11739. eCollection 2023 Jan.
5
A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
J Interv Cardiol. 2018 Apr;31(2):136-143. doi: 10.1111/joic.12461. Epub 2017 Nov 23.
6
Safety and efficacy of prourokinase injection in patients with ST-elevation myocardial infarction: phase IV clinical trials of the prourokinase phase study.
Heart Vessels. 2018 May;33(5):507-512. doi: 10.1007/s00380-017-1097-x. Epub 2017 Dec 5.
7
Retracted: Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke.
Evid Based Complement Alternat Med. 2023 Dec 13;2023:9761312. doi: 10.1155/2023/9761312. eCollection 2023.
8
Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
Lancet. 2017 Aug 19;390(10096):747-759. doi: 10.1016/S0140-6736(17)31441-1.
9
Efficacy of half-dose recombinant human prourokinase thrombolysis combined with early PCI in 48 patients with ST-segment-elevation myocardial infarction (STEMI).
Asian J Surg. 2023 Apr;46(4):1658-1659. doi: 10.1016/j.asjsur.2022.09.115. Epub 2022 Oct 6.
10
Retracted: Research on Influencing Factors of Clinical Efficacy of Meniscus Resection Based on Logistic Regression Analysis.
Scanning. 2023 Jun 21;2023:9817461. doi: 10.1155/2023/9817461. eCollection 2023.
本文引用的文献
1
Comparison of Efficacy and Safety of Recombinant Human Prourokinase and Alteplase in the Treatment of STEMI and Analysis of Influencing Factors of Efficacy.
Evid Based Complement Alternat Med. 2021 Sep 6;2021:6702965. doi: 10.1155/2021/6702965. eCollection 2021.
Zotero 插件